PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
32417267-5	2020	Furthermore, pre-treatment of HER2 x mPEG BsAb enhanced the tumor accumulation and retention of Lipo-DiR 2.2-fold in HER2-high expressing MCF7/HER2 tumors as compared to HER2-low expressing MCF7/neo1 tumors.	mpeg bsab	37-46	erb-b2 receptor tyrosine kinase 2	Homo sapiens	30-34
32417267-5	2020	Furthermore, pre-treatment of HER2 x mPEG BsAb enhanced the tumor accumulation and retention of Lipo-DiR 2.2-fold in HER2-high expressing MCF7/HER2 tumors as compared to HER2-low expressing MCF7/neo1 tumors.	mpeg bsab	37-46	erb-b2 receptor tyrosine kinase 2	Homo sapiens	117-121
32417267-5	2020	Furthermore, pre-treatment of HER2 x mPEG BsAb enhanced the tumor accumulation and retention of Lipo-DiR 2.2-fold in HER2-high expressing MCF7/HER2 tumors as compared to HER2-low expressing MCF7/neo1 tumors.	mpeg bsab	37-46	erb-b2 receptor tyrosine kinase 2	Homo sapiens	117-121
32417267-5	2020	Furthermore, pre-treatment of HER2 x mPEG BsAb enhanced the tumor accumulation and retention of Lipo-DiR 2.2-fold in HER2-high expressing MCF7/HER2 tumors as compared to HER2-low expressing MCF7/neo1 tumors.	mpeg bsab	37-46	erb-b2 receptor tyrosine kinase 2	Homo sapiens	117-121
32417267-5	2020	Furthermore, pre-treatment of HER2 x mPEG BsAb enhanced the tumor accumulation and retention of Lipo-DiR 2.2-fold in HER2-high expressing MCF7/HER2 tumors as compared to HER2-low expressing MCF7/neo1 tumors.	mpeg bsab	37-46	neogenin 1	Homo sapiens	195-199